Normalized T1 Magnetic Resonance Imaging for Assessment of Regional Lung Function in Adult Cystic Fibrosis Patients - A Cross-Sectional Study

Elliott C. Dasenbrook(Cleveland Clinic), Chris A. Flask(Case Western Reserve University), Peter M. Jakob(Ordensklinikum Linz Barmherzige Schwestern), Vikas Gulani(Case Western Reserve University), David E. Weaver(University Hospitals Cleveland Medical Center), Michael W. Konstan(Case Western Reserve University), Lan Lŭ(Cleveland Clinic), Shannon Donnola(University Hospitals Cleveland Medical Center)
PLoS ONE
September 25, 2013
10.1371/journal.pone.0073286
Cited by 22

Related Papers

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation
|New England Journal of Medicine|2010|802
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation
|Thorax|2011|501
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial
|The Lancet Respiratory Medicine|2014|442
Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic Fibrosis
|The Journal of Pediatrics|2007|441